"10.1371_journal.pone.0048385","plos one","2012-11-12T00:00:00Z","Marie-José C van Lierop; Wynand Alkema; Anke J Laskewitz; Rein Dijkema; Hans M van der Maaden; Martin J Smit; Ralf Plate; Paolo G M Conti; Christan G J M Jans; C Marco Timmers; Constant A A van Boeckel; Scott J Lusher; Ross McGuire; Rene C van Schaik; Jacob de Vlieg; Ruben L Smeets; Claudia L Hofstra; Annemieke M H Boots; Marcel van Duin; Benno A Ingelse; Willem G E J Schoonen; Aldo Grefhorst; Theo H van Dijk; Folkert Kuipers; Wim H A Dokter","Department of Immune Therapeutics, MSD, Oss, The Netherlands; Department of Molecular Design and Informatics, MSD, Oss, The Netherlands; Department of Pediatrics, Center for Liver Digestive and Metabolic Diseases, University Medical Center Groningen, Groningen, The Netherlands; Molecular Pharmacology Department, MSD, Oss, The Netherlands; Medicinal Chemistry Department, MSD, Oss, The Netherlands; Womens Health Department, MSD, Oss, The Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands; Toxicology and Drug Disposition, MSD, Oss, The Netherlands; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands","Conceived and designed the experiments: MvL WA AL RD HvdM RP PC CJ SL RS CH AB WS AG TvD WD. Performed the experiments: MvL WA AL RD HvdM RP PC CJ SL RS CH WS AG TvD FK. Analyzed the data: MvL WA AL RD HvdM RP PC CJ SL RS CH AB WS AG TvD FK WD. Contributed reagents/materials/analysis tools: MvL WA AL RD HvdM MS RP PC CJ CT CvB SL RvS JdV RS CH AB MvD BI WS AG TvD FK WD. Wrote the paper: MvL WA AL RD HvdM RP PC SL RS CH AB WS AG TvD FK WD. Managing and providing tools/scientific input in the research project from their specific discipline: MS CT CvB RM RvS JdV MvD BI FK WD.","The authors have read the journals policy and have the following conflicts. The following co-authors are or were employees at Merck at the time the work described in this manuscript was performed: M.J.C. van Lierop, W. Alkema, R. Dijkema, H. van der Maaden, M.J. Smit, R. Plate, P.G.M. Conti, C.G.J.M. Jans, C.M. Timmers, C.A.A. van Boeckel, S.J. Lusher, R. McGuire, R.C. van Schaik, J. de Vlieg, R. Smeets, C.L. Hofstra, A.M.H. Boots, M. van Duin, B.A. Ingelse, W.G.J.E. Schoonen and W. Dokter. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. The research described in this manuscript was funded by Top Institute Pharma (TIPharma), a nonprofit organization that catalyzes medicine development by founding partnerships between academia and industry. The co-author A.J. Laskewitz was employed by TIPharma. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.","2012","11","Marie-José C van Lierop","MJCVL",25,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
